Timothy Johnson
Presidente presso Nonagen Bioscience Corp.
Profilo
Timothy B.
Johnson is currently the Executive Chairman at Nonagen Bioscience Corp.
Prior to this, he was the Chief Executive Officer at Codetta Bio, Inc. and the Executive Chairman at HTG Molecular Diagnostics, Inc. He also served as Co-Chairman at Bioscience Leadership Council, Director at Kalypto Medical, Inc., Senior Vice President-Global Business Services at Ventana Medical Systems, Inc., Senior Manager-Consulting at Pricewaterhouse LLP, Vice President-Global Marketing at Hill-Rom, Inc., and Vice President & General Manager at Hill Rom Air Shields.
Mr. Johnson received his undergraduate degree from Indiana University.
Posizioni attive di Timothy Johnson
| Società | Posizione | Inizio |
|---|---|---|
Nonagen Bioscience Corp.
 Nonagen Bioscience Corp. BiotechnologyHealth Technology Nonagen Bioscience Corp. is a privately held biotechnology company that focuses on reducing the burden of cancer with innovative diagnostics. The company is currently seeking US Food and Drug Administration approval for Oncuria as an in vitro diagnostic test. The company is based in Los Angeles, CA. The company is committed to bringing best-in-class, noninvasive diagnostics for cancer detection, therapy choice, and disease monitoring to the market. Nonagen's lead diagnostic for bladder cancer, Oncuria®, is available as a laboratory developed test through Diacarta Laboratories. The company is developing diagnostics for bladder, breast, and prostate cancers. Nonagen Bioscience is physician-led and was founded in 2011. The company was founded in 2011 by Charles Joel Rosser, who has been the CEO since then. | Presidente | 27/04/2023 |
Precedenti posizioni note di Timothy Johnson
| Società | Posizione | Fine |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Amministratore Delegato | 31/03/2019 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 30/03/2007 |
Codetta Bio, Inc.
 Codetta Bio, Inc. BiotechnologyHealth Technology Codetta Bio, Inc. is a company that researches and develops a quantitative and digital spatial platform for nucleic acid and protein assays. The company is based in Morrisville, NC. The CEO of the company is Anthony V. Lemmo. | Amministratore Delegato | - |
| Bioscience Leadership Council | Presidente | - |
Hill Rom Air Shields
 Hill Rom Air Shields Medical SpecialtiesHealth Technology Part of Drägerwerk AG & Co. KGaA, Hill Rom Air Shields develops care warming therapy, incubators, and other infant care products. The company is based in Hatboro, PA. Hill Rom Air Shields was acquired by Drägerwerk AG & Co. KGaA from Hill-Rom Holdings, Inc. on June 24, 2004. | Corporate Officer/Principal | - |
Formazione di Timothy Johnson
| Indiana University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| Aziende private | 8 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Kalypto Medical, Inc.
 Kalypto Medical, Inc. Medical SpecialtiesHealth Technology Kalypto Medical, Inc. manufactured medical devices. Its devices were used to treat diabetic leg ulcers. The firm also provided wound-care products. The company was founded in 2006 and was headquartered in Hastings, MN. | Health Technology |
| Pricewaterhouse LLP | Commercial Services |
Hill-Rom, Inc.
 Hill-Rom, Inc. Medical DistributorsDistribution Services Hill-Rom, Inc. provides medical equipment and services. The company was founded on October 23, 1929 and is headquartered in Batesville, IN. | Distribution Services |
Hill Rom Air Shields
Hill Rom Air Shields Medical SpecialtiesHealth Technology Part of Drägerwerk AG & Co. KGaA, Hill Rom Air Shields develops care warming therapy, incubators, and other infant care products. The company is based in Hatboro, PA. Hill Rom Air Shields was acquired by Drägerwerk AG & Co. KGaA from Hill-Rom Holdings, Inc. on June 24, 2004. | Health Technology |
| Bioscience Leadership Council | |
Nonagen Bioscience Corp.
Nonagen Bioscience Corp. BiotechnologyHealth Technology Nonagen Bioscience Corp. is a privately held biotechnology company that focuses on reducing the burden of cancer with innovative diagnostics. The company is currently seeking US Food and Drug Administration approval for Oncuria as an in vitro diagnostic test. The company is based in Los Angeles, CA. The company is committed to bringing best-in-class, noninvasive diagnostics for cancer detection, therapy choice, and disease monitoring to the market. Nonagen's lead diagnostic for bladder cancer, Oncuria®, is available as a laboratory developed test through Diacarta Laboratories. The company is developing diagnostics for bladder, breast, and prostate cancers. Nonagen Bioscience is physician-led and was founded in 2011. The company was founded in 2011 by Charles Joel Rosser, who has been the CEO since then. | Health Technology |
Codetta Bio, Inc.
Codetta Bio, Inc. BiotechnologyHealth Technology Codetta Bio, Inc. is a company that researches and develops a quantitative and digital spatial platform for nucleic acid and protein assays. The company is based in Morrisville, NC. The CEO of the company is Anthony V. Lemmo. | Health Technology |
- Borsa valori
- Insiders
- Timothy Johnson